Product
DCP-001
3 clinical trials
3 indications
Indication
Acute Myeloid LeukemiaIndication
Dendritic Cell VaccinationIndication
Ovarian CancerClinical trial
An International, Multicentre, Open-label Study To Evaluate The Efficacy and Safety of Two Different Vaccination Regimens of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia That Are In Remission With Persistent MRDStatus: Active (not recruiting), Estimated PCD: 2023-03-01
Clinical trial
Phase 1 Study of Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid LeukemiaStatus: Completed, Estimated PCD: 2013-02-01
Clinical trial
An Open Label, Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary TreatmentStatus: Active (not recruiting), Estimated PCD: 2025-06-01